Company intelligence
Aurion Biotech
We're on a mission to cure blindness with our transformational platform of advanced therapies.
Biotechnology
Seattle, US
117 employees
Founded 2022
2 public signals
About Aurion Biotech
Aurion Biotech, Inc. (Aurion Biotech) is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness. Our first candidate is for the treatment of corneal endothelial disease, and one of the first clinically validated cell therapies for corneal care. CAUTION: New Drug—Limited by Federal (or United States) law to investigational use.
Verified activity
Signals from Aurion Biotech
2 published signals
Presence & Recognition
Aurion Biotech is attending the ESCRS 2026 Congress in London, United Kingdom from September 11 to 15, 2026.
Reported by Aurion Biotech
Research & Knowledge
Aurion Biotech research, clinical experience, and perspectives from leaders in the field shape its approach to corneal endothelial disease.
Reported by Aurion Biotech